Ledger.Open graph →
SEC Form D · filed November 23, 2016

Spring Bank Pharmaceuticals, Inc

Offering
$15.0M
Sold
$15.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HOPKINTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Jonathan K. Bates · Hopkinton, MADirectorDavid K. Arkowitz · Hopkinton, MADirectorMartin Driscoll · Hopkinton, MAExec · DirectorR.P. K. Iyer · Hopkinton, MADirectorNezam Afdhal · Hopkinton, MAExecJonathan Freve · Hopkinton, MAExecKurt M. Eichler · Destin, FLDirectorJonathan K. Bates · Hopkinton, MADirectorR.P. K. Iyer · Hopkinton, MADirectorDavid K. Arkowitz · Hopkinton, MADirectorNezam Afdhal · Hopkinton, MAExecJonathan Freve · Hopkinton, MAExecMartin Driscoll · Quebec, Quebec, CanadaExec · DirectorKurt M. Eichler · Hopkinton, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗